Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mareike Peters

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Plos One|October 25, 2022
Data platforms for open life sciences-A systematic analysis of management instrumentsDaniel Laufs, Mareike Peters, Carsten Schultz
Haematologica|October 16, 2025
Lenalidomide-associated reversible TP53-mutated clonal hematopoiesis in plasma cell neoplasmsChristian B Gocke, Mareike Peters, Christopher D Gocke, et al.
Journal of Cellular and Molecular Medicine|September 5, 2023
Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemiaAdrian Bogdan Tigu, Catalin Sorin Constantinescu, Patric Teodorescu, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Plos One|October 25, 2022
Data platforms for open life sciences-A systematic analysis of management instrumentsDaniel Laufs, Mareike Peters, Carsten Schultz
Haematologica|October 16, 2025
Lenalidomide-associated reversible TP53-mutated clonal hematopoiesis in plasma cell neoplasmsChristian B Gocke, Mareike Peters, Christopher D Gocke, et al.
Journal of Cellular and Molecular Medicine|September 5, 2023
Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemiaAdrian Bogdan Tigu, Catalin Sorin Constantinescu, Patric Teodorescu, et al.
Pageof 1